The Society of Interventional Oncology NCCN Committee spearheaded an effort in 2019 to provide input into the 2020 update of Kidney Cancer NCCN guidelines. SIO brought our RCC task force together and helped us through the specifics of the NCCN submission process.
MSK Workshop Chair, Dr. Jack Jennings of Washington University Saint Louis, shares his perspective on SIO as he leads the SIO2020 Program Committee planning of the second annual Musculoskeletal Interventional Oncology Workshop at SIO2020.
Dr. Suh is a clinical Professor in the Department of Radiological Sciences at the Ronald Reagan UCLA Medical Center and the David Geffen School of Medicine at UCLA. Currently, he serves as Scientific Chair on the SIO2020 Program Committee.
SIO Publications Committee Co-Chair, Dr. Christos Georgiades of Johns Hopkins University, shares his perspective on his career in IO, his committee work, and the importance of SIO as the field grows.
SIO Research Committee Chair, Dr. Martijn Meijerink of Amsterdam UMC, shares his perspective on his career in IO, his committee work, and the importance of SIO as the field grows.
Controversy erupted at the HCC Evidence-based Practice Debates at WCIO 2016 regarding combination therapy for HCC. Panelist, expert and author Karen Brown, MD from Memorial Sloan-Kettering Cancer Center responds: